FDA's ban on Apotex India plant stems from faked test data

Apotex's Bangalore facility--Courtesy of Apotex

In April, the FDA banned a plant in Bangalore, India, owned by Canadian generics maker Apotex. An FDA warning letter posted today explains why: The company deleted data from failed test results, a practice the FDA had warned about during inspections dating back 8 years, the agency said. Report